{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:55:59Z","timestamp":1765382159830},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 69-year-old man with biochemical recurrence after radical prostatectomy underwent 6 months of androgen deprivation therapy. Upon discontinuation of androgen deprivation therapy, serum prostate-specific antigen rose again to 0.69 ng\/mL, and <jats:sup>18<\/jats:sup>F-DCFPyL PET\/CT was performed to identify the site of recurrence. However, only an intense focus of uptake in the spleen could be found. Subsequent contrast-enhanced MRI findings were pathognomonic for splenic hemangioma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002428","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T20:29:55Z","timestamp":1548275395000},"page":"255-256","source":"Crossref","is-referenced-by-count":12,"title":["Splenic Hemangioma as a Potential Pitfall on PSMA-Targeted 18F-DCFPyL PET\/CT"],"prefix":"10.1097","volume":"44","author":[{"given":"Guillaume","family":"Chauss\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gad","family":"Abikhzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Probst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/RLU.0000000000001731","article-title":"Extraosseous extension of aggressive vertebral hemangioma as a potential pitfall on 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/RLU.0000000000001384","article-title":"Prostate-specific membrane antigen PET\/CT findings for hepatic hemangioma","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1097\/RLU.0000000000001542","article-title":"Subcutaneous lobular capillary hemangioma on 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1148\/rg.254045154","article-title":"MR imaging of the spleen: spectrum of abnormalities","volume":"25","year":"2005","journal-title":"Radiographics"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1148\/radiology.202.1.8988207","article-title":"Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions","volume":"202","year":"1997","journal-title":"Radiology"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/MPH.0000000000000665","article-title":"A rare presentation of isolated congenital splenic hemangioma with Kasabach-Merritt syndrome","volume":"39","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/1752-1947-8-390","article-title":"Klippel-Trenaunay syndrome presenting with acanthocytosis and splenic and retroperitoneal lymphangioma: a case report","volume":"8","journal-title":"J Med Case Reports"},{"key":"bib8-20230925","first-page":"357","article-title":"Hemangiomatosis of the spleen in a patient with Klippel-Tr\u00e9naunay syndrome","volume":"96","year":"2013","journal-title":"JBR-BTR"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.12659\/AJCR.907356","article-title":"Von Hippel\u2013Lindau disease with multi-organ involvement: a case report and 8-year clinical course with follow-up","volume":"18","year":"2017","journal-title":"Am J Case Rep"},{"key":"bib10-20230925","first-page":"2674","article-title":"Prostate-specific membrane antigen is produced in tumor-associated neovasculature","volume":"5","year":"1999","journal-title":"Clin Cancer Res"},{"key":"bib11-20230925","first-page":"287","article-title":"Correlation between PSMA and VEGF expression as markers for LNCaP tumor angiogenesis","year":"2005","journal-title":"J Biomed Biotechnol"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2006.07.8097","article-title":"Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors","volume":"25","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201903000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:09:29Z","timestamp":1695618569000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201903000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002428","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}